Michael Konstan
Vice Chair for Clinical Research, Department of Pediatrics, School of Medicine · Case Western Reserve University
Credentials: · ·
History
- Present
Department of Pediatrics · Case Western Reserve University
PresentClinical Research · Case Western Reserve University/University Hospitals Cleveland Medical Center
- 1982–1983
Kaleida Health System Women And Children's Hosp Of Buffalo)
- 1974–1978
Research
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation
New England Journal of Medicine · 2011 · 1,787 citations
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
New England Journal of Medicine · 2015 · 1,166 citations
Review · American Journal of Respiratory and Critical Care Medicine · 1996 · Last of 3 authors · 743 citations
49 papers
- JW
40 papers
19 papers
18 papers
- FA
16 papers
16 papers
16 papers
15 papers
Grants
- 2018–2023
Clinical and Translational Science Collaborative of Cleveland
National Center for Advancing Translational Sciences · UL1
Contact PI · $23.6M · Case Western Reserve University
- 2019
Personalized Small Molecule Therapy for Severe Asthma and Cystic Fibrosis.
National Heart, Lung, and Blood Institute · P01
Project lead · $1.1M · Indiana University Indianapolis
- 2007–2018
Clinical and Translational Science Collaborative of Cleveland
National Center for Advancing Translational Sciences · UL1
Contact PI · $19.7M · Case Western Reserve University
- 2007–2018
Clinical and Translational Science Collaborative of Cleveland
National Center for Advancing Translational Sciences · KL2
Contact PI · $4.5M · Case Western Reserve University
Clinical trials
- 2018–2026
CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes
Principal investigator · Active not recruiting
Nicole Hamblett
- 2007–2009
Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers
Principal investigator · Completed
University Hospitals Cleveland Medical Center
- 2007
Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis
Principal investigator · Completed · Phase 3
Digestive Care, Inc.
- 2006–2007
Principal investigator · Completed
University Hospitals Cleveland Medical Center